ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors.
about
Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment.Involvement of NOS2 Activity on Human Glioma Cell Growth, Clonogenic Potential, and Neurosphere GenerationArginine and the metabolic regulation of nitric oxide synthesis in cancer
P2860
ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
ASP9853, an inhibitor of induc ...... tudy in advanced solid tumors.
@ast
ASP9853, an inhibitor of induc ...... tudy in advanced solid tumors.
@en
type
label
ASP9853, an inhibitor of induc ...... tudy in advanced solid tumors.
@ast
ASP9853, an inhibitor of induc ...... tudy in advanced solid tumors.
@en
prefLabel
ASP9853, an inhibitor of induc ...... tudy in advanced solid tumors.
@ast
ASP9853, an inhibitor of induc ...... tudy in advanced solid tumors.
@en
P2093
P2860
P1476
ASP9853, an inhibitor of induc ...... tudy in advanced solid tumors.
@en
P2093
Allam Fakhoury
Andrew Krivoshik
Carl Dmuchowski
Geoffrey I Shapiro
Jason J Luke
Jeffrey R Infante
Patricia LoRusso
Robin Schuster
Takao Yamazaki
Yukinori Arai
P2860
P2888
P304
P356
10.1007/S00280-016-2967-0
P577
2016-01-25T00:00:00Z